Skip to main content
Premium Trial:

Request an Annual Quote

Cellomics, GE Healthcare to Co-Develop Cellular Imaging Informatics Platform

NEW YORK, June 29 (GenomeWeb News) - Cellomics and GE Healthcare will co-develop an informatics platform for analyzing data from GE Healthcare's cellular imaging systems, the companies said today.

 

The firms will collaborate to develop and market a software interface that will integrate data and images from GE Healthcare's IN Cell Analyzer 3000 and IN Cell Analyzer 1000 sub-cellular imaging systems with Cellomics' Cellomics Store and vHCS Discovery ToolBox informatics tools.

 

Last week, Cellomics said that GE Healthcare -- formed by the merger of Amersham Biosciences and GE Medical Systems in April -- had licensed its portfolio of high-content screening patents in a non-exclusive agreement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.